| has gloss | eng: AbioCor is an artificial heart developed by the Massachusetts-based company AbioMed. It is fully implantable within a patient, due to a combination of advances in miniaturization, biosensors, plastics and energy transfer that has made this advance possible. The AbioCor runs on a rechargeable source of power. The internal battery is charged by a transcutaneous energy transmission (TET) system, meaning that no wires or tubes penetrate the skin and therefore there is less risk of infection. After being initially rejected by FDA circulatory system devices advisory panel in 2005, it was approved by the Food and Drug Administration on September 5, 2006 as a Humanitarian Use Device because of its limited market. Because of its size, this heart is only compatible with men who have a large frame. It has a product life expectancy of 18 months. |
